75 results
8-K
EX-1.1
FATE
Fate Therapeutics Inc
20 Mar 24
Fate Therapeutics Announces Pricing of $100 Million Underwritten Offering and Concurrent Private Placement
5:32pm
to be classified as a PFIC for any subsequent taxable year.
(ss) Compliance with Laws. The Company and its subsidiaries have been and are in compliance with all
424B5
FATE
Fate Therapeutics Inc
20 Mar 24
Prospectus supplement for primary offering
5:30pm
as compensation for services.
In addition, if a partnership, including any entity or arrangement classified as a partnership for U.S. federal income tax … other foreign organization classified as a corporation for U.S. federal income tax purposes, (ii) a nonresident alien individual, or (iii) a foreign
8-K
EX-1.1
4xew8qo
4 Nov 21
Entry into a Material Definitive Agreement
4:59pm
S-3ASR
EX-1.2
pse qq2zudp0
4 Nov 21
Automatic shelf registration
4:56pm